Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol

INTRODUCTION: The combination of biomarkers and drugs is the subject of growing interest both from regulators, physicians and companies. This study protocol of a systematic review is aimed to describe available literature evidences about the cost-effectiveness, cost-utility or net-monetary benefit o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mucherino, Sara, Lorenzoni, Valentina, Orlando, Valentina, Triulzi, Isotta, Del Re, Marzia, Capuano, Annalisa, Danesi, Romano, Turchetti, Giuseppe, Menditto, Enrica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438832/
https://www.ncbi.nlm.nih.gov/pubmed/34497081
http://dx.doi.org/10.1136/bmjopen-2020-048141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438832/
https://www.ncbi.nlm.nih.gov/pubmed/34497081
http://dx.doi.org/10.1136/bmjopen-2020-048141

Ejemplares similares